This is an old revision of the document!
National Advisory Committee on Immunization
The National Advisory Committee on Immunization (NACI) is a Canadian advisory body operating within the Public Health Agency of Canada (PHAC).1)
Members
Current
Former
Name | Position | Notes |
---|---|---|
Natalie Dayneka | Member | - |
Soren Gantt | Member | Funding from GlaxoSmithKline, Merck, Moderna, Pfizer |
Coleman Rotstein | Member | Funding from Astellas, Avir Pharma, Chimerix, Cidara Therapeutics, Merck, Pendopharm, Pfizer, Roche, Sunovion, and Teva |
Althea House | Manager | - |
Deborah Danoff | Ex-officio representative for the Marketed Health Products Directorate | - |
Julie Emili | Liaison representative for the College of Family Physicians of Canada | - |
Jennifer Pennock | Ex-officio representative for the Surveillance and Epidemiology Division of the Centre for Immunization and Respiratory Infectious Diseases (CIRID) at Public Health Agency of Canada | - |
Robert Pless | Ex-officio representative for the Biologics and Genetic Therapies Directorate at Health Canada | - |
1)
Public Health Agency of Canada. (2022, September 16). National Advisory Committee on Immunization (NACI): Terms of reference. Government of Canada. https://web.archive.org/web/20230406185629/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/terms-references.html
2)
Where Are They Now: Nicole Forbes. (2020, November 20). BioCanRx. https://web.archive.org/web/20230316080334/https://biocanrx.com/now-nicole-forbes